NKGen Biotech, Inc. is a clinical-stage biotechnology company. The Company is focused on the development and commercialization of autologous, allogeneic, and CAR-NK natural killer cell therapies to treat neurodegenerative and oncological diseases uti... Read more
CNBC
MarketWatch
CNBC
Yahoo
Access detailed stock analysis from LSEG including analyst price target estimates.